Original Query: ALL
Previous Study | Return to List | Next Study

Efficacy of Lapaquistat Acetate Co-Administered With Current Lipid-Lowering Treatment on Blood Cholesterol Levels in Subjects With Homozygous Familial Hypercholesterolemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00263081
Recruitment Status : Terminated (Overall profile of the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents)
First Posted : December 7, 2005
Last Update Posted : May 24, 2012
Information provided by (Responsible Party):